Emblem of India
India Science, Technology and Innovation Portal (ISTI) Department of Science & Technology GOVERNMENT OF INDIA
Towards a new dawn
×

img Accessibility Controls

Research Banner

All Research Areas

Total Records: 12

Filter Research

Title Research Area Implementing Organisations Funding Organisations Start Year Status
A Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Testicular Safety of Filgotinib in Adult Males with Moderately to Severely Active Ulcerative Colitis Medical Sciences All India Institute of Medical Sciences (AIIMS) Gilead Sciences, Inc., USA 2019 Completed
A randomized, Double-blind, Placebo and Active controlled, Multicenter, Phase 3 Study to Access the Efficacy and Safety of Filgotinib Administered for 52 Weeks Alone and in Combination with Methotrexate (MTX) to Subjects with Moderately to Severely Active Rheumatoid Arthritis who Are Naive to MTX Therapy Medical Sciences All India Institute of Medical Sciences (AIIMS) Gilead Sciences, Inc., USA 2018 Completed
Association of Lipid mediators of inflammation with TB treatment outcomes Medical Sciences National Institute for Research in Tuberculosis (ICMR-NIRT), Tamil Nadu Gilead Sciences, Inc., USA 2018 Completed
Cryptococcal Infections in Non HIV Infected Hosts: A Prospective International Study (MSG-11) Medical Sciences Postgraduate Institute of Medical Education & Research (PGIMER) Gilead Sciences, Inc., USA 2018 Completed
A randomized, double-blind, placebo and active controlled, multicenter, phase 3 study to access the efficacy and safety of Filgotinib administered for 52 weeks in combination with Methotrexate (MTX) to subjects with moderately to severely active rheumatoid arthritis, who have an inadequate response to methotrexate Medical Sciences All India Institute of Medical Sciences (AIIMS) Gilead Sciences, Inc., USA 2018 Completed
A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis Medical Sciences All India Institute of Medical Sciences (AIIMS) Gilead Sciences, Inc., USA 2017 Completed
Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to severely active crohn?s disease Medical Sciences All India Institute of Medical Sciences (AIIMS) Gilead Sciences, Inc., USA 2017 Completed
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH) Medical Sciences All India Institute of Medical Sciences (AIIMS) Gilead Sciences, Inc., USA 2017 Completed
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis Medical Sciences All India Institute of Medical Sciences (AIIMS) Gilead Sciences, Inc., USA 2017 Completed
A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohns Disease Medical Sciences All India Institute of Medical Sciences (AIIMS) Gilead Sciences, Inc., USA 2017 Completed
arrowtop
Latest Updates
Loading…
Recently added across the portal